Concepedia

Impact of first wave of SARS-CoV-2 infection in patients with Systemic Lupus Erythematosus: Weighting the risk of infection and flare

Dina Zucchi, Chiara Tani, Elena Elefante, Chiara Stagnaro, Linda Carli, Viola Signorini, Francesco Ferro, Francesca Trentin, Giovanni Fulvio, Chiara Cardelli,

PLoS ONE · 2021 · 21 citations · 8 references

DOIFull text

Open access

Abstract

Treatment discontinuation seems to be an important cause of disease flare. Our findings suggest that abrupt drug withdrawal should be avoided or evaluated with caution on the basis of individual infection risk and comorbidities.

References

8

RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola et al. · International Journal of Antimicrobial Agents · 2020 · 4.9K citations · Full text

, , +4

Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies

Jianjun Gao, Zhenxue Tian, Xu Yang · BioScience Trends · 2020 · 2.7K citations · Full text

, , +19

2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

Martin Aringer, Karen H. Costenbader, David Daikh et al. · Arthritis & Rheumatology · 2019 · 2.3K citations · Full text

Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State

Eli S. Rosenberg, Elizabeth Dufort, Tomoko Udo et al. · JAMA · 2020 · 1.2K citations · Full text

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola et al. · 2020 · 1.1K citations · Full text

, , +13